Comparative efficacy of two primary care interventions to assist withdrawal from long term benzodiazepine use: A protocol for a clustered, randomized clinical trial

BMC Family Practice

Volumn 12, Issue , 2011, Pages

  Vicens, Caterina ^a   Socias, Isabel ^a   Mateu, Catalina ^a   Leiva, Alfonso ^b   Bejarano, Ferran ^c   Sempere, Ermengol ^d   Basora, Josep ^e   Palop, Vicente ^f   Mengual, Marta ^c   Beltran, Jose Luis ^g   Aragonès, Enric ^c   Lera, Guillem ^h   Folch, Silvia ^c   Pĩol, Josep Lluís ^c   Esteva, Magdalena ⁱ   Roca, Miguel ^j   Arenas, Arturo ^k   Del Mar Sureda, María ^k   Campoamor, Francisco ^l   Fiol, Francisca ^a  

^a Balearic Mental Health Research Group (RediAPP Primary Care Research Network)   (Spain)

^b CAIBER   (Spain)

^c Reus Tarragona Research Group (RediAPP Primary Care Research Network)   (Spain)

^d Paterna Health Care Centre   (Spain)

^e INSTITUT D INVESTIGACIÓ SANITÀRIA PERE VIRGILI IISPV   (Spain)

^f Balearic Mental Health Clinical Group (RediAPP Primary Care Research Network)   (Spain)

^g Altabix Health Care Centre   (Spain)

^h Hospital La Ribera   (Spain)

ⁱ Balearic Health Service IbSalut   (Spain)

^j UNIVERSITAT DE LES ILLES BALEARS   (Spain)

^k Balearic Mental Health Clinical Group (RediAPP Primary Care Research Network)   (Spain)

^l HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE DERIVATIVE;

ADDICTION; ADOLESCENT; ADULT; AGED; ANXIETY; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; HUMAN; INTERVIEW; METHODOLOGY; MIDDLE AGED; MULTICENTER STUDY; PATIENT EDUCATION; PRIMARY HEALTH CARE; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; WITHDRAWAL SYNDROME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANXIETY; BENZODIAZEPINES; DEPRESSION; HUMANS; INTERVIEWS AS TOPIC; MIDDLE AGED; PATIENT EDUCATION AS TOPIC; PRIMARY HEALTH CARE; RESEARCH DESIGN; SINGLE-BLIND METHOD; SUBSTANCE WITHDRAWAL SYNDROME; SUBSTANCE-RELATED DISORDERS; YOUNG ADULT;

EID: 79954627149     PISSN: None     EISSN: 14712296     Source Type: Journal    
DOI: 10.1186/1471-2296-12-23     Document Type: Article

References (36)

1. Benzodiazepine consumption in Spain. P Rayon D Montero B Santamaría, Eur J Clin Pharmacol 1997 52 321 3 10.1007/s00228-997-4015-9 9248774
2. Different study criteria affect the prevalence of benzodiazepine use. SM Zandstra JW Furer EH Van de Lisdonk M Hof Van't JHJ Bor C Van Weel FG Zitman, Soc Psychiatr Epidemiol 2002 37 139 44 10.1007/s001270200006 (Pubitemid 36097270)
3. The Use of Ansiolytic and Hypnotic Drugs in Spain (1995-2002). J García del Pozo F Iglesias Abajo A García-Pando Carvajal D Corominas Montero M Sanz Madurga V García del Pozo, Rev Esp Salud Publica 2004 78 379 87 15293958 (Pubitemid 38915375)
4. monografía en Internet. Encuesta Nacional de Salud de Espãa 2006, Madrid: Ministerio de Sanidad y Consumo 2008 http://www.msc.es/ estadEstudios/estadisticas/encuestaNacional/encuestaNac2006/ UtilizacionServiciosSanitariosAbsoluto.xls accessed 2nd February 2011
5. monografía en Internet. Observatorio del Uso de Medicamentos de la AEMPS, Madrid: Agencia Espãola de Medicamentos y Productos Sanitarios http://www.aemps.es/profHumana/observatorio/docs/ansioliticos-hipnoticos.pdf Accessed 2nd february 2011
6. Consumption of antidepressants and benzodiazepines in our Communities. C Vicens E Sempere V Palop A Moral M Zaforteza A Prat, II Congress of the Catalan, Valencian and Balearic Societies of Family and Community Medicine Castellon 2008 12 2 3 Revista Valenciana de Medicina Familiar
7. Benzodiazepines and the risk of falling leading to femur fractures. Dosage more important than elimination half-life. RM Herings BH Stricker A De Boer A Bakker F Sturmans, Arch Intern Med 1995 155 1801 7 10.1001/archinte.155. 16.1801 7654115
8. Hazardous benzodiazepine regimens in the elderly: effects of a half-life, dosage, and duration on risk of hip fracture. PS Wangs RL Bohn RJ Glynn H Mogun J Avorn, Am J Psychiatry 2001 158 892 8 11384896 (Pubitemid 32547618)
9. Medication use and risk of falls. CI Neutel S Perry C Maxwell, Pharmacoepidemiol Drug Safety 2002 11 97 104 10.1002/pds.686 (Pubitemid 34464329)
10. Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits. J Glass K Lanctot N Herrman A Sproule U Busto, BMJ 2005 331 1169 10.1136/bmj.38623.768588.47 16284208
11. Is usage of hypnotics associated with mortality? L Mallon JE Broman J Hetta, Sleep Medicine 2009 10 279 86 10.1016/j.sleep.2008.12.004 19269892
12. Mortality hazard associated with anxiolitic and hypnotic drug use in the National Population Health Survey. G Belleville, Can J Psychiatry 2010 55 558 67 20840803
13. Guía de Prescripcián Terapéutica (GPT) Adaptacián espãola de la 51°ed. del British National Formulary (BNF) 1°ed. Espãola. Ministerio de Sanidad y Consumo (MSC), Barcelona: Pharma Editores S.L 2006
14. Grupo de Trabajo de la Guía de Prctica Clínica para el Manejo de Pacientes con Insomnio en Atencián Primaria, Guías de Prctica Clínica en el SNS: UETS 2009 5 1 Guía de Prctica Clínica para el Manejo de Pacientes con Insomnio en Atencián Primaria. Plan de Calidad para el Sistema Nacional de Salud del Ministerio de Sanidad y Política Social. Unidad de Evaluacián de Tecnologías Sanitarias. Agencia Laín Entralgo. Comunidad de Madrid
15. Grupo de Trabajo de la Guía de Prctica Clínica para el Manejo de Pacientes con Trastornos de Ansiedad en Atencián Primaria, Guías de Prctica Clínica en el SNS: UETS 2008 10 Guía de Prctica Clínica para el Manejo de Pacientes con Trastornos de Ansiedad en Atencián Primaria. Plan de Calidad para el Sistema Nacional de Salud del Ministerio de Sanidad Unidad de Evaluacián de Tecnologías Sanitarias. Agencia Laín Entralgo. Comunidad de Madrid
16. Depression. The treatment and management of depression in adults. National Collaborating Centre for Mental Health, London (UK): National Institute for Health and Clinical Excellence (NICE) 2009 64 Clinical guideline; no. 90
17. Anxiety: management of anxiety (panic disorder, with or without agoraphobia, and generalised anxiety disorder) in adults in primary, secondary and community care. National Collaborating Centre for Mental Health, London (UK): National Institute for Health and Clinical Excellence (NICE) 2004 88 Clinical guideline; no. 22
18. Elevado consumo de benzodiacepinas en mujeres ancianas asignadas a centros de salud urbanos de atencián primaria. F Romero Bejarano JL Moreso Pĩol N Gilabert Mora P Luque Claver N Lápez Brull J Gallisa Basora, Aten Primaria 2008 40 617 21 10.1016/S0212-6567(08)75695-6 19100149
19. Patterns and correlates of benzodiazepine use in the French general population. R Lagnaoui F Depont A Fourrier A Abouelfath B Begaud H Verdoux N Moore, Eur J Clin Pharmacol 2004 60 523 9 10.1007/s00228-004-0808-2 15338086 (Pubitemid 39350165)
20. Controlled comparison of the characteristics of long term benzodiazepine users in general practice. RJ Simpson KG Power LA Wallace MH Butcher V Swanson EC Simpson, Br J Gen Pract 1990 40 22 26 1969288 (Pubitemid 20078518)
21. Withdrawal from long-term benzodiazepine use: randomised trial in family practice. C Vicens F Fiol J Llobera F Campoamor C Mateu S Alegret I Socías, Br J Gen Pract 2006 56 958 63 17132385 (Pubitemid 44941795)
22. Strategies for discontinuing long-term benzodiazepine use. RC Vosahar Oude JE Couvée A Van Balkom P Mulder FG Zitman, British J Psychiatry 2006 189 213 20 10.1192/bjp.189.3.213 (Pubitemid 44343465)
23. Effectiveness of current treatment approaches for benzodiazepine discontinuation: a meta-analysis. JM Parr DJ Kavanagh L Cahill G Mitchell R McD Young, Addiction 2008 104 13 24 18983627
24. Evaluation of an easy, cost-effective strategy for cutting benzodiazepine use in general practice. MA Cormack KG Sweeney H Hughes-Jones GA Foot, Br J Gen Pract 1994 44 5 8 8312045 (Pubitemid 24025904)
25. Controlled evaluation of brief intervention by general practitioners to reduce chronic use of benzodiazepines. K Bashir M King M Ashworth, Br J Gen Pract 1994 44 408 12 8790654 (Pubitemid 24292665)
26. Discontinuation of long-term benzodiazepine use by sending a letter to users in family practice: a prospective controlled intervention study. WJ Gorgels RC Vosahar Oude AJ Mol EH Van de Lisdonk AJ Van Balkom HJM Van den Hoogen J Mulder MH Breteler FG Zitman, Drug and Alcohol Depend 2005 78 49 56 10.1016/j.drugalcdep.2004.09.001 (Pubitemid 40354176)
27. Discontinuation of benzodiazepines among older insomniac adults treated with cognitive-behavioural therapy combined with gradual tapering: a randomized trial. L Baillargeon P Landreville R Verreault JP Beauchemin JP Grégoire CM Morin, CMAJ 2003 169 1015 1020 14609970 (Pubitemid 37449350)
28. Tapering off long-term benzodiazepine use with or without group cognitive-behavioral therapy: three condition, randomized controlled trial. RC Voshaar Oude W Gorgels AJ Mol AJ Van Balkom EH Van de Lisdonk MH Breteler HJ van den Hoogen FG Zitman, Br J Psychiatry 2003 182 498 504 10.1192/bjp.182.6.498 12777340 (Pubitemid 36649195)
29. Randomized clinical trial of supervised tapering and cognitive behavior therapy to facilitate benzodiazepine discontinuation on older adults with chronic insomnia. CM Morin C Bastien B Guay M Radouco-Thomas J Leblanc A Vallieres, Am J Psychiatry 2004 161 332 42 10.1176/appi.ajp.161.2.332 14754783 (Pubitemid 38425457)
30. Pharmacological interventions for benzodiazepine mono-dependence management in outpatients settings. C Denis M Fatséas E Lavie M Auriacombe, Cochrane Database Syst Rev 2006
31. The hospital anxiety and depression scale. AS Zigmond RP Snaith, Acta Psychiatr Scand 1983 67 361 370 10.1111/j.1600-0447.1983.tb09716.x 6880820 (Pubitemid 13098606)
32. Evaluation of the psychometric characteristics of the Spanish version of the Hospital Anxiety and Depression Scale. JM Quintana A Padierna C Esteban I Arostegui A Bilbao I Ruiz, Acta Psychiatr Scand 2003 107 216 21 10.1034/j.1600-0447.2003.00062.x 12580829 (Pubitemid 36250282)
33. The Severity of Dependence Scale (SDS) as screening test for benzodiazepine dependence: SDS validation study. C De las Cuevas E Sanz JA De la Fuente J Padilla JC Berenguer, Addiction 2000 95 245 50 10.1046/j.1360-0443. 2000.95224511.x 10723853 (Pubitemid 30111245)
34. Propiedades psicométricas del cuestionario Oviedo de suẽo. J Bobes MP Gonzlez PA Siz MT Bascarn C Iglesias JM Fernndez, Psicothema 2000 12 107 12
35. Causality classification at pharmacovigilance centers in the European Community. RHB Meyboom RJ Royer, Pharmacoepidemiol Drug Safety 1992 1 87 9 10.1002/pds.2630010207
36. Sample size calculations for cluster randomised trials. Changing Professional Practice in Europe Group (EU BIOMED II Concerted Action). M Campbell J Grimshaw N Steen, J Health Serv Res Policy 2000 5 12 6 10787581